The Enterprise Value as of December 2025 (TTM) for Genetics Generation Advancement Corp. (4160.TWO) is 1.26B

According to Genetics Generation Advancement Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.26B. This represents a change of -28.55% compared to the average of 1.76B of the last 4 quarters.

Genetics Generation Advancement Corp. (4160.TWO) Historical Enterprise Value (quarterly & annually)

How has 4160.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Genetics Generation Advancement Corp. over the last ten years is 813.87M. The current 1.26B Enterprise Value has changed 15.38% with respect to the historical average. Over the past ten years (40 quarters), 4160.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 3.12B. The Enterprise Value was at its lowest in in the March 2023 quarter at 619.45M.

Genetics Generation Advancement Corp. (4160.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genetics Generation Advancement Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genetics Generation Advancement Corp. (4160.TWO) Average Enterprise Value

How has 4160.TWO Enterprise Value performed in the past?

The current Enterprise Value of Genetics Generation Advancement Corp. (4160.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genetics Generation Advancement Corp. (4160.TWO) Enterprise Value vs. Peers

How is 4160.TWO’s Enterprise Value compared to its peers?

Genetics Generation Advancement Corp.’s Enterprise Value is less than Kim Forest Enterprise Co., Ltd. (1.42B), less than Lagis Enterprise Co., Ltd. (1.69B), less than Bioptik Technology Incorporation (1.62B), less than Perfect Medical Industry Co., Ltd. (1.71B), less than NaviFUS Corp. (1.30B), less than BiOptic Inc. (1.32B), less than Acer Medical Inc. (1.57B), less than Enimmune corporation (1.35B), less than Tien Liang BioTech Co., Ltd. (1.76B), less than GenMont Biotech Incorporation (1.63B),

Build a custom stock screener for Genetics Generation Advancement Corp. (4160.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetics Generation Advancement Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetics Generation Advancement Corp. (4160.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetics Generation Advancement Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.